Suchergebnisse - Alejo Rodríguez‐Vida

  • Treffer 1 - 20 von 20
Treffer weiter einschränken
  1. 1
    New treatment options for metastatic renal cell carcinoma

    New treatment options for metastatic renal cell carcinoma von Alejo Rodríguez‐Vida, Thomas E. Hutson, Joaquim Bellmunt, Michiel Strijbos

    Veröffentlicht 2017
    Volltext Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  2. 2
    Enzalutamide for the treatment of metastatic castration-resistant prostate cancer

    Enzalutamide for the treatment of metastatic castration-resistant prostate cancer von Alejo Rodríguez‐Vida, Simon Chowdhury, Cora N. Sternberg, Sarah Rudman, Myria Galazi

    Veröffentlicht 2015
    Volltext Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  3. 3
    LBA23 Pembrolizumab (P) combined with chemotherapy (C) vs C alone as first-line (1L) therapy for advanced urothelial carcinoma (UC): KEYNOTE-361

    LBA23 Pembrolizumab (P) combined with chemotherapy (C) vs C alone as first-line (1L) therapy for advanced urothelial carcinoma (UC): KEYNOTE-361 von Ajjai Alva, Tibor Csőszi, Mustafa Özgüroğlu, Nobuaki Matsubara, Lajos Géczi, Sierra Cheng, Yves Fradet, Stéphane Oudard, Christof Vulsteke, Rafael Morales-Bárrera, Aude Fléchon, Şeyda Gündüz, Yohann Loriot, Alejo Rodríguez‐Vida, Ronac Mamtani, Evan Y. Yu, K. Nam, Kazuo Imai, Blanca Homet Moreno, Thomas Powles

    Veröffentlicht 2020
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  4. 4
    Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS)

    Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS) von Petros Grivas, Yohann Loriot, Rafael Morales‐Barrera, Min Yuen Teo, Yousef Zakharia, Susan Feyerabend, Nicholas J. Vogelzang, Enrique Grande, Nabil Adra, Ajjai Alva, Andrea Necchi, Alejo Rodríguez‐Vida, Sumati Gupta, Debra H. Josephs, S. Srinivas, Kenton Wride, Daleen Thomas, Andrew D. Simmons, Andrea Loehr, Rachel L. Dusek, Dale Nepert, S. Chowdhury

    Veröffentlicht 2021
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  5. 5
    Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non–Muscle-Invasive Bladder Cancer

    Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non–Muscle-Invasive Bladder Cancer von Joaquim Bellmunt, Jaegil Kim, Brendan Reardon, Júlia Perera‐Bel, Anna Orsola, Alejo Rodríguez‐Vida, Stephanie A. Wankowicz, Michaela Bowden, Justine A. Barletta, Juan Moróte, Inés de Torres, Núria Juanpere, Josep Lloreta, Sílvia Hernández, Kent W. Mouw, Mary‐Ellen Taplin, Paloma Cejas, Henry W. Long, Eliezer M. Van Allen, Gad Getz, David J. Kwiatkowski

    Veröffentlicht 2020
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  6. 6
    Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

    Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial von Thomas Powles, Mark Kockx, Alejo Rodríguez‐Vida, Ignacio Durán, Simon J. Crabb, Michiel S. van der Heijden, Bernadett Szabados, Albert Font Pous, Gwénaëlle Gravis, Urbano Anido, Andrew Protheroe, Alain Ravaud, Denis Maillet, María José Méndez, Cristina Suárez, Mark Linch, Aaron Prendergast, Pieter‐Jan van Dam, Diana Stanoeva, Sofie Daelemans, Sanjeev Mariathasan, Joy S. Tea, Kelly Mousa, Romain Banchereau, Daniel Castellano

    Veröffentlicht 2019
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  7. 7
    Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trial

    Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trial von Bertrand Tombal, Ananya Choudhury, Farid Saad, E. Gallardo, Andrey Soares, Yohann Loriot, Ray McDermott, Alejo Rodriguez-Vida, Pedro Isaacsson Velho, Franco Nolè, Felipe José Silva Melo Cruz, Thierry Roumeguère, Gedske Daugaard, Rosely Yamamura, Emmanuelle Bompas, Pablo Maroto, F Gómez Veiga, Iwona Skoneczna, Karine Martins da Trindade, Flavio Mavignier Cárcano, Frédéric Lecouvet, Corneel Coens, Coralie Poncet, B. Fournier, S. Gillessen

    Veröffentlicht 2025
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  8. 8
    Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients

    Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients von Natàlia Jiménez, Marta García de Herreros, Òscar Reig, Mercedes Marín‐Aguilera, Caterina Aversa, Laura Ferrer‐Mileo, Samuel García-Esteve, Leonardo Rodríguez‐Carunchio, Isabel Trias, Albert Font, Alejo Rodríguez‐Vida, Miguel Ángel Climent, Sara Cros, Isabel Chirivella, Montserrat Domènech, Mariona Figols, Joan Carles, Cristina Suárez, D. Herrero Rivera, Enrique González‐Billalabeitia, Claudia Cívico, Núria Sala‐González, Vicenç Ruiz de Porras, María J. Ribal, Aleix Prat, Begoña Mellado

    Veröffentlicht 2024
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  9. 9
    Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer

    Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer von Vincenza Conteduca, Anuradha Jayaram, Nuria Romero-Laorden, Daniel Wetterskog, Samanta Salvi, Giorgia Gurioli, Emanuela Scarpi, Elena Castro, Mercedes Marín‐Aguilera, Cristian Lolli, Giuseppe Schepisi, Antonio Maugeri, Anna Wingate, Alberto Farolfi, Valentina Casadio, Ana Medina, Javier Puente, Ma José Méndez Vidal, Rafael Morales-Bárrera, José Carlos Villa-Guzmán, Susana Hernando, Alejo Rodríguez‐Vida, Aránzazu González del Alba, Begoña Mellado, Enrique González‐Billalabeitia, David Olmos, Gerhardt Attard, Ugo De Giorgi

    Veröffentlicht 2018
    Volltext
    Carta
    Zu den Favoriten
    Gespeichert in:
  10. 10
    Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder

    Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder von Bernadett Szabados, Mark Kockx, Zoe J. Assaf, Pieter‐Jan van Dam, Alejo Rodríguez‐Vida, Ignacio Durán, Simon J. Crabb, Michiel S. van der Heijden, Albert Font Pous, Gwénaëlle Gravis, Urbano Anido Herranz, Andrew Protheroe, Alain Ravaud, Denis Maillet, María José Méndez, Cristina Suárez, Mark Linch, Aaron Prendergast, Charlotte Tyson, Diana Stanoeva, Sofie Daelemans, Miche Rombouts, Sanjeev Mariathasan, Joy S. Tea, Kelly Mousa, Shruti Sharma, Alexey Aleshin, Romain Banchereau, Daniel Castellano, Thomas Powles

    Veröffentlicht 2022
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  11. 11
    Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study

    Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study von Natalie Miller, Ali Raza Khaki, Leonidas Nikolaos Diamantopoulos, Mehmet Asım Bilen, Víctor Sacristán Santos, Neeraj Agarwal, Rafael Morales‐Barrera, Michael Devitt, Ariel Ann Nelson, Christopher Hoimes, Evan Shreck, Hussein Assi, Benjamin A. Gartrell, Alex Sankin, Alejo Rodríguez‐Vida, Mark P. Lythgoe, David J. Pinato, Alexandra Drakaki, Monika Joshi, Pedro Isaacsson Velho, Noah M. Hahn, Sandy Liu, Lucía Alonso Buznego, Ignacio Durán, Marcus W. Moses, Jayanshu Jain, Jure Murgić, Pedro Barata, Abhishek Tripathi, Yousef Zakharia, Matthew D. Galsky, Guru Sonpavde, Evan Y. Yu, Gary H. Lyman, Petros Grivas

    Veröffentlicht 2020
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  12. 12
    Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): “Real World” Experience

    Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): “Real World” Experience von Dimitra Rafailia Bakaloudi, Rafee Talukder, Genevieve Ihsiu Lin, Dimitrios Makrakis, Leonidas Nikolaos Diamantopoulos, Nishita Tripathi, Neeraj Agarwal, Roubini Zakopoulou, Aristotelis Bamias, Jason R. Brown, David J. Pinato, James Korolewicz, Tanya Jindal, Vadim S. Koshkin, Jure Murgić, Marija Miletić, Ana Fröbe, Jeffrey S. Johnson, Yousef Zakharia, Alexandra Drakaki, Alejo Rodríguez‐Vida, Macarena Rey-Cárdenas, Daniel Castellano, Lucía Alonso Buznego, Ignacio Durán, Clara Castro Carballeira, Rafael Morales-Bárrera, David Marmorejo, Rana R. McKay, Tyler F. Stewart, Shilpa Gupta, Andrew Ruplin, Evan Y. Yu, Ali Raza Khaki, Petros Grivas

    Veröffentlicht 2023
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  13. 13
    Impact of performance status on treatment outcomes: A real‐world study of advanced urothelial cancer treated with immune checkpoint inhibitors

    Impact of performance status on treatment outcomes: A real‐world study of advanced urothelial cancer treated with immune checkpoint inhibitors von Ali Raza Khaki, Ang Li, Leonidas Nikolaos Diamantopoulos, Mehmet Asım Bilen, Víctor Sacristán Santos, John Esther, Rafael Morales-Bárrera, Michael Devitt, Ariel Ann Nelson, Christopher Hoimes, Evan Shreck, Hussein Assi, Benjamin A. Gartrell, Alex Sankin, Alejo Rodríguez‐Vida, Mark P. Lythgoe, David J. Pinato, Alexandra Drakaki, Monika Joshi, Pedro Isaacsson Velho, Noah M. Hahn, Sandy Liu, Lucía Alonso Buznego, Ignacio Durán, Marcus Marie Moses, Jayanshu Jain, Jure Murgić, Praneeth Baratam, Pedro Barata, Abhishek Tripathi, Yousef Zakharia, Matthew D. Galsky, Guru Sonpavde, Evan Y. Yu, Veena Shankaran, Gary H. Lyman, Petros Grivas

    Veröffentlicht 2019
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  14. 14
    A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors

    A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors von Ali Raza Khaki, Ang Li, Leonidas Nikolaos Diamantopoulos, Natalie Miller, Lucía Carril-Ajuria, Daniel Castellano, Ivan de Kouchkovsky, Vadim S. Koshkin, Joseph J. Park, Ajjai Alva, Mehmet Asım Bilen, Tyler F. Stewart, Víctor Sacristán Santos, Neeraj Agarwal, Jayanshu Jain, Yousef Zakharia, Rafael Morales-Bárrera, Michael Devitt, Ariel Ann Nelson, Christopher Hoimes, Evan Shreck, Benjamin A. Gartrell, Alex Sankin, Abhishek Tripathi, Roubini Zakopoulou, Aristotelis Bamias, Alejo Rodríguez‐Vida, Alexandra Drakaki, Sandy Liu, Vivek Kumar, Mark P. Lythgoe, David J. Pinato, Jure Murgić, Ana Fröbe, Monika Joshi, Pedro Isaacsson Velho, Noah M. Hahn, Lucía Alonso Buznego, Ignacio Durán, Marcus W. Moses, Pedro C. Barata, Matthew D. Galsky, Guru Sonpavde, Evan Y. Yu, Veena Shankaran, Gary H. Lyman, Petros Grivas

    Veröffentlicht 2021
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  15. 15
    Association of prior local therapy and outcomes with programmed‐death ligand‐1 inhibitors in advanced urothelial cancer

    Association of prior local therapy and outcomes with programmed‐death ligand‐1 inhibitors in advanced urothelial cancer von Dimitrios Makrakis, Rafee Talukder, Leonidas Nikolaos Diamantopoulos, Lucía Carril-Ajuria, Daniel Castellano, Ivan de Kouchkovsky, Vadim S. Koshkin, Joseph J. Park, Ajjai Alva, Mehmet Asım Bilen, Tyler F. Stewart, Rana R. McKay, Víctor Sacristán Santos, Neeraj Agarwal, Jayanshu Jain, Yousef Zakharia, Rafael Morales-Bárrera, Michael Devitt, Michael Grant, Mark P. Lythgoe, David J. Pinato, Ariel Ann Nelson, Christopher Hoimes, Evan Shreck, Benjamin A. Gartrell, Alex Sankin, Abhishek Tripathi, Roubini Zakopoulou, Aristotelis Bamias, Jure Murgić, Ana Fröbe, Alejo Rodríguez‐Vida, Alexandra Drakaki, Sandy Liu, Vivek Kumar, Giuseppe Di Lorenzo, Monika Joshi, Pedro Isaacsson‐Velho, Lucía Alonso Buznego, Ignacio Durán, Marcus W. Moses, Pedro C. Barata, Guru Sonpavde, Evan Y. Yu, Jonathan L. Wright, Petros Grivas, Ali Raza Khaki

    Veröffentlicht 2021
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  16. 16
    Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma

    Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma von Dimitrios Makrakis, Rafee Talukder, Genevieve Ihsiu Lin, Leonidas Nikolaos Diamantopoulos, Scott J. Dawsey, Shilpa Gupta, Lucía Carril-Ajuria, Daniel Castellano, Ivan de Kouchkovsky, Vadim S. Koshkin, Joseph J. Park, Ajjai Alva, Mehmet Asım Bilen, Tyler F. Stewart, Rana R. McKay, Nishita Tripathi, Neeraj Agarwal, Naomi Vather-Wu, Yousef Zakharia, Rafael Morales-Bárrera, Michael Devitt, Alessio Cortellini, Claudia Angela Maria Fulgenzi, David J. Pinato, Ariel Ann Nelson, Christopher Hoimes, Kavita Gupta, Benjamin A. Gartrell, Alex Sankin, Abhishek Tripathi, Roubini Zakopoulou, Aristotelis Bamias, Jure Murgić, Ana Fröbe, Alejo Rodríguez‐Vida, Alexandra Drakaki, Sandy Liu, Eric Lu, Vivek Kumar, Giuseppe Di Lorenzo, Monika Joshi, Pedro Isaacsson‐Velho, Lucía Alonso Buznego, Ignacio Durán, Marcus W. Moses, Albert Jang, Pedro Barata, Guru Sonpavde, Evan Y. Yu, Bruce Montgomery, Petros Grivas, Ali Raza Khaki

    Veröffentlicht 2022
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  17. 17
    Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma

    Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma von Rafee Talukder, Dimitrios Makrakis, Genevieve Ihsiu Lin, Leonidas Nikolaos Diamantopoulos, Scott J. Dawsey, Shilpa Gupta, Lucía Carril-Ajuria, Daniel Castellano, Ivan de Kouchkovsky, Tanya Jindal, Vadim S. Koshkin, Joseph J. Park, Ajjai Alva, Mehmet Asım Bilen, Tyler F. Stewart, Rana R. McKay, Nishita Tripathi, Neeraj Agarwal, Naomi Vather-Wu, Yousef Zakharia, Rafael Morales-Bárrera, Michael Devitt, Alessio Cortellini, Claudia Angela Maria Fulgenzi, David J. Pinato, Ariel Ann Nelson, Christopher Hoimes, Kavita Gupta, Benjamin A. Gartrell, Alex Sankin, Abhishek Tripathi, Roubini Zakopoulou, Aristotelis Bamias, Jure Murgić, Ana Fröbe, Alejo Rodríguez‐Vida, Alexandra Drakaki, Sandy Liu, Eric Lu, Vivek Kumar, Giuseppe Di Lorenzo, Monika Joshi, Pedro Isaacsson‐Velho, Lucía Alonso Buznego, Ignacio Durán, Marcus W. Moses, Pedro C. Barata, Guru Sonpavde, Jonathan L. Wright, Evan Y. Yu, Bruce Montgomery, Andrew C. Hsieh, Petros Grivas, Ali Raza Khaki

    Veröffentlicht 2022
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  18. 18
    HSD3B1 (1245A>C) germline variant and clinical outcomes in metastatic castration-resistant prostate cancer patients treated with abiraterone and enzalutamide: results from two prospective studies

    HSD3B1 (1245A>C) germline variant and clinical outcomes in metastatic castration-resistant prostate cancer patients treated with abiraterone and enzalutamide: results from two p... von Daniel Khalaf, Isabel M. Aragón, Matti Annala, Rosa M. Lozano, Sinja Taavitsainen, David Lorente, Daygen L. Finch, Nuria Romero-Laorden, Joanna Vergidis, Ylenia Cendón, Conrad D. Oja, M.I. Pacheco, Maria Zulfiqar, Martin Gleave, Alexander W. Wyatt, David Olmos, K.N. Chi, Elena Castro, Elena Almagro, José Ángel Arranz, Enrique González‐Billalabeitia, Pablo Borrega, Elena Castro, J.A. Cuello Contreras, Marta Domènech, Ricardo Sánchez-Escribano, E. Fernández-Parra, Enrique Gallardo, I. García-Carbonero, R. García, J. Garde, Aránzazu González del Alba, Belén González Sánchez, Amaia Hernández, Susana Hernando, Pablo Gálvez Jiménez, Núria Laínez, David Lorente, Raquel Luque, E. Martínez García, Ana Medina, María José Méndez-Vidal, A. Montesa, Rafael Morales, David Olmos, Jose Luis Pérez‐Gracia, Begoña Pérez‐Valderrama, Ana Catarina Pinto, Josep M. Piulats, Javier Puente, Rosa Querol, Alejo Rodríguez‐Vida, Nuria Romero-Laorden, M.I. Sáez, Sergio Vázquez‐Estévez, Erik Velez, José Carlos Villa-Guzmán, R. Villatoro, C. Zambrana

    Veröffentlicht 2020
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  19. 19
    Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

    Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, do... von Daniel P. Petrylak, Ronald de Wit, Kim N., Alexandra Drakaki, Cora N. Sternberg, Hiroyuki Nishiyama, Daniel Castellano, Syed A. Hussain, Aude Fléchon, Aristotelis Bamias, Evan Y. Yu, Michiel S. van der Heijden, Nobuaki Matsubara, B. Yа. Alekseev, Andrea Necchi, Lajos Géczi, Yen‐Chuan Ou, Hasan Şenol Çoşkun, Wen-Pin Su, Miriam Hegemann, Ivor Percent, Jae‐Lyun Lee, Marcello Tucci, Andrey Semenov, Fredrik Laestadius, Avivit Peer, Giampaolo Tortora, Sufia Safina, Xavier García del Muro, Alejo Rodríguez‐Vida, İrfan Çiçin, Hakan Harputluoğlu, Ryan C. Widau, Astra M. Liepa, Richard A. Walgren, Oday Hamid, Annamaria H. Zimmermann, Katherine M. Bell‐McGuinn, Thomas Powles, Suet-Lai Shirley Wong, Thean Hsiang Tan, Elizabeth Hovey, Timothy Clay, Siobhan Ng, Annemie Rutten, Jean‐Pascal Machiels, Herlinde Dumez, Susanna Y. Cheng, Kim Nguyen, Cristiano Ferrario, Lisa Sengeloev, Niels Viggo Jensen, Constance Thibault, Brigitte Laguerre, Fredrik Laestadius, Florence Joly, Aude Fléchon, Stéphane Culine, Catherine Becht, Günter Niegisch, Michael Stöckle, Marc‐Oliver Grimm, Georgios Gakis, Wolfgang Schultze‐Seemann, Haralabos P. Kalofonos, Dimitriοs Mavroudis, Christos N. Papandreou, Vasilios Karavasilis, Aristotelis Bamias, János Révész, Lajos Géczi, Eli Rosenbaum, Raya Leibowitz‐Amit, Daniel Kejzman, Avivit Peer, David Sarid, Giorgio V. Scagliotti, Cora N. Sternberg, Giampaolo Tortora, Sergio Bracarda, Andrea Necchi, Francesco Massari, Takahiro Osawa, Naoto Miyajima, Nobuo Shinohara, Fumimasa Fukuta, Chikara Οhyama, Wataru Obara, Shinichi Yamashita, Yoshihiko Tomita, Koji Kawai, Satoshi Fukasawa, Nobuaki Matsubara, Masafumi Oyama, Junji Yonese, Masayoshi Nagata, Motohide Uemura, Kazuo Nishimura, Mutsushi Kawakita, Hiroyuki Tsunemori

    Veröffentlicht 2017
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  20. 20
    Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial

    Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival... von Daniel P. Petrylak, Ronald de Wit, Kim N., Alexandra Drakaki, Cora N. Sternberg, Hiroyuki Nishiyama, Daniel Castellano, Syed A. Hussain, Aude Fléchon, Aristotelis Bamias, Evan Y. Yu, Michiel S. van der Heijden, Nobuaki Matsubara, B. Yа. Alekseev, Andrea Necchi, Lajos Géczi, Yen-Chuan Ou, Hasan Şenol Çoşkun, Wen‐Pin Su, Jens Bedke, Georgios Gakis, Ivor Percent, Jae‐Lyun Lee, Marcello Tucci, Andrey Semenov, Fredrik Laestadius, Avivit Peer, Giampaolo Tortora, Sufia Safina, Xavier García del Muro, Alejo Rodríguez‐Vida, İrfan Çiçin, Hakan Harputluoğlu, Scott T. Tagawa, Ulka N. Vaishampayan, Jeanny B. Aragon‐Ching, Oday Hamid, Astra M. Liepa, Sameera R. Wijayawardana, Francesca Russo, Richard A. Walgren, Annamaria H. Zimmermann, Rebecca R. Hozak, Katherine M. Bell‐McGuinn, Thomas Powles, Suet-Lai Shirley Wong, Thean Hsiang Tan, Elizabeth Hovey, Timothy Clay, Siobhan Ng, Annemie Rutten, Jean-Pascal Machiels, Herlinde Dumez, Susanna Y. Cheng, Cristiano Ferrario, Lisa Sengeloev, Niels Viggo Jensen, Constance Thibault, Brigitte Laguerre, Florence Joly, Stéphane Culine, Catherine Becht, Günter Niegisch, Michael Stöckle, Marc‐Oliver Grimm, Christina A Schwentner, Wolfgang Schultze‐Seemann, Haralabos P. Kalofonos, Dimitriοs Mavroudis, Christos N. Papandreou, Vasilios Karavasilis, János Révész, Eli Rosenbaum, Raya Leibowitz‐Amit, Daniel Kejzman, David Sarid, Giorgio V. Scagliotti, Sergio Bracarda, Francesco Massari, Takahiro Osawa, Naoto Miyajima, Nobuo Shinohara, Fumimasa Fukuta, Chikara Οhyama, Wataru Obara, Shinichi Yamashita, Yoshihiko Tomita, Koji Kawai, Satoshi Fukasawa, Masafumi Oyama, Junji Yonese, Masayoshi Nagata, Motohide Uemura, Kazuo Nishimura, Mutsushi Kawakita, Hiroyuki Tsunemori, Katsuyoshi Hashine, Junichi Inokuchi, Akira Yokomizo, Satoshi Nagamori

    Veröffentlicht 2019
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: